MYLAN 1650 MYLAN 1650
Pill imprint MYLAN 1650 MYLAN 1650 has been identified as Nitrofurantoin macrocrystals 50 mg.
Nitrofurantoin is used in the treatment of urinary tract infection; bladder infection; prevention of bladder infection and belongs to the drug class urinary anti-infectives. There is no proven risk in humans during pregnancy.
Nitrofurantoin 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Nitrofurantoin macrocrystals Images
- Imprint:
-
MYLAN 1650
MYLAN 1650 - Strength:
- 50 mg
- Color:
- Beige
- Size:
- 12.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- ferric oxide black
corn starch
D&C Yellow No. 10 Aluminium Lake
FD&C Blue No. 1 Aluminium Lake
FD&C Blue No. 2 Aluminium Lake
FD&C Red No. 40 Aluminium Lake
gelatin
lactose monohydrate
magnesium stearate
ferric oxide red
silicon dioxide
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
- Drug Class:
- Urinary anti-infectives
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1650
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0584 | UDL Laboratories Inc |
| 54569-0181 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
More Nitrofurantoin Macrocrystals resources
- Nitrofurantoin
- Nitrofurantoin (Wolters Kluwer)
- Nitrofurantoin Suspension (Wolters Kluwer)
- nitrofurantoin (Cerner Multum)
- Novo-Furan Suspension (Micromedex) - Includes Dosage Information
- nitrofurantoin (Micromedex) - Includes Dosage Information
- Nitrofurantoin (AHFS DI)
- Nitrofurantoin Capsules (FDA)
- Nitrofurantoin Macrocrystals (FDA)
- Nitrofurantoin Oral Suspension (FDA)
- Nitrofurantoin (Wolters Kluwer)


